Markets Sink in Global Selloff; Pharma, IT Lead Sharp Declines as Tariff Worries Bite

📰Daily Market Wrap-Up by Stock Whisperers- September 26, 2025

September 26, 2025

📈 Market Overview:

Market Overview

Summary of the Day's Market Performance

  • The Sensex tumbled 733.22 points (-0.90%) to close at 80,426.46, extending its losing streak.

  • The Nifty plunged 236.15 points (-0.95%) to 24,654.70, dipping below 24,700.

  • Midcap and Smallcap indices shed 2% each, amplifying broader market weakness.

  • All sectoral indices ended in the red, with Bank, Capital Goods, Consumer Durables, Metal, IT, Telecom, Pharma, and PSU Bank down 1-2%.

💸 Market Transactions:

  • Foreign Institutional Investors (FII): Sold ₹5,687.58 crore

  • Domestic Institutional Investors (DII): Bought ₹5,843.21 crore

DII buying narrowly offset FII outflows, but couldn't stem the bloodbath.

📊📑 Important Observations and Market Sentiments: Editor Special

  • The Indian market mirrored Asian routs, with sentiment rattled by fresh U.S. tariffs targeting pharmaceuticals, dragging the sector deep into the red. Accenture’s weaker guidance and job cuts underscored slowing IT spending, with AI growth falling short, triggering a broad tech sell-off.

  • Investors remain cautious, focusing on domestic investment and consumption amid global uncertainty. Structural reforms (GST 2.0 effective September 22) and a normal monsoon provide a buffer, but tariff escalation (50% on September 11) and geopolitical risks (Russia-Ukraine) loom. Near-term consolidation is likely, with Nifty support at 24,500.

DO YOU KNOW?

The U.S. pharma tariffs, effective today, impose a 25% levy on Indian generics, potentially adding $2 billion in annual costs for exporters like Sun Pharma and Dr Reddy's Labs.

📰Stock News:

Key Stock Movements and News

  • Top Gainers: L&T, Tata Motors, Eicher Motors, Reliance Industries, and ITC

  • Top Losers: IndusInd Bank, Sun Pharma, M&M, Eternal, and Tata Steel

  • L&T rallied over 3% after Telangana took over Hyderabad Metro’s debt, paying ₹2,000 crore as a one-time settlement.

  • Carysil plunged up to 10% after Trump’s 50% tariffs on kitchen equipment imports, though the company clarified no impact on kitchen sinks.

  • Tata Motors rose 2% after JLR restored some systems hit by a cyberattack, with closures until October 1.

  • Waaree Energies plunged 8% on a U.S. probe into suspected solar tariff evasion via ‘Made in India’ labeling.

  • Ceigall India rose 2% on a ₹509 crore project win from GMADA.

  • RITES gained 6% on a locomotive supply order from Talis Logistics in South Africa.

  • GK Energy shares debuted with a 12% premium on NSE, listing at ₹165.20 on BSE (8% premium).

  • Alcobrew Distilleries filed IPO papers for a ₹258 crore fresh issue, with promoter Romesh Pandita selling 1.8 crore shares via OFS.

Markets Ride Fed Cut Wave, All Eyes on India–US Trade Talks

Weekly Stock Markets Rundown: September 22-26, 2025

The week of September 22-26, 2025, builds on Nifty's surge above 25,100 and Sensex at 81,904.70, with Fed cut tailwinds and trade deal hopes driving optimism. Goyal's visit to the US (Sep 22) and the US PCE data (Sep 26) will be pivotal, alongside flash PMIs and earnings from Adani Green and HDFC Life. Nifty's bullish setup above 25,000 persists, supported by DIIs despite FII caution; September 24 eyed for momentum. Focus on renewables, consumer, insurance, and industrials amid easing inflation and global positivity.

👀Stocks to Focus:

  • L&T: Debt relief momentum to monitor.

  • Waaree Energies: Tariff probe impact to watch.

  • RITES: Export order strength to observe.

📝Summary:

Indian markets fell 0.95%, with Nifty below 24,700, as pharma tariffs and IT spending fears triggered a seventh straight loss. Metals gained on China support, while IT and Auto lagged. DII buying nearly matched FII outflows—focus on trade talks and Q2 GDP next week!

😊Thank you for subscribing to our Market Wrap-Up. Stay tuned for tomorrow's update.

Disclaimer: The Stock Whisperers is a media platform providing educational and informational content related to the stock market. We do not offer investment advice, stock recommendations, or tips. Readers should consult a SEBI-registered advisor before making any investment decisions.